News on Lung Diseases
|
News Release
NIH-supported physician-scientists are studying how primary care providers can identify and treat more people with chronic obstructive pulmonary disease A new tool shows promise in helping primary care physicians identify adults with undiagnosed chronic obstructive pulmonary disease (COPD), according to research published in JAMA. More than 15...
|
Statement
Findings from a randomized, non-blinded, phase 3 clinical trial supported by the National Institutes of Health found no significant difference in 90-day mortality rates, nor safety concerns, after providing patients with one of two common treatment strategies for sepsis. The findings were published in the New England Journal of Medicine and were...
|
News Release
A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has formally concluded that the drug provides no clinical benefit to hospitalized patients. Though found not to cause harm, early findings in June when the trial was...
|
Research Feature
NIH researchers can maintain image quality from different scanning systems while reducing or avoiding radiation exposure When doctors want detailed images of the lungs, more often than not they turn to chest CT scans. Over the years these scans have been particularly useful in diagnosing lung diseases—so useful, in fact, that in the United States...
|
News Release
Researchers have identified 57 genetic variations of a gene strongly associated with declines in blood oxygen levels during sleep. Low oxygen levels during sleep are a clinical indicator of the severity of sleep apnea, a disorder that increases the risk of heart disease, dementia, and death. The study, published today in the American Journal of...
|
Research Feature
Might pave the way for new and improved treatments for a wide variety of respiratory diseases Maps may be great tools for helping you find your way around unfamiliar places, but in the future, a new type of map well might help save your life. Welcome to the Molecular Atlas of Lung Development Program, or LungMAP, a historic effort to help...
|
News Release
A new study provides evidence to support a simple measurement for diagnosing clinically significant airflow obstruction, the key characteristic of chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States. The study found that a 70% ratio of two indicators of lung function proved as or more accurate than...